ALK translocations are more prevalent among individuals in their fourth or fifth decade of life, considerably younger than both patients with NSCLC (median age of 70 years) and patients with tumors harboring EGFR mutations (60–65 years) [49,52]. Here, ALK is linked to non-small cell lung carcinoma.